Safety aspects related to recombinant protein expression from Semliki Forest virus vectors
Kenneth Lundström(Nanotherapeutics (United States)), Ernst‐Jürgen Schlaeger(Roche (Switzerland))
Cited by 7
Related Papers
Viral Vectors for COVID-19 Vaccine Development
|Viruses|2021|92